The New Official Journal of the IASLC
International Association for the Study of Lung Cancer: The First Three Decades
Pick the Winner Designs in Phase II Cancer Clinical Trials
The Ras/Raf/MAPK Pathway
Practitioner Feedback on Lung Cancer Practice Guidelines in Ontario
A Randomized Phase II Trial Using Two Different Treatment Schedules of Gemcitabine and Carboplatin in Patients with Advanced Non–Small-Cell Lung Cancer
Pemetrexed Maintenance Therapy in Patients with Malignant Pleural Mesothelioma
A Literature Review of Molecular Markers Predictive of Clinical Response to Cytotoxic Chemotherapy in Patients with Lung Cancer
Phase I Study of Paclitaxel Given by Seven-Week Continuous Infusion Concurrent with Radiation Therapy for Locally Advanced Non–Small Cell Lung Cancer
A Novel Classification of MUC1 Expression Is Correlated with Tumor Differentiation and Postoperative Prognosis in Non–Small Cell Lung Cancer
Combined Analysis of Molecular and Clinical Predictors of Gefitinib Activity in Advanced Non–Small Cell Lung Cancer: Epidermal Growth Factor Receptor Mutations Do Not Tell the Whole Story
Lung Cancer Screening Using Multi-Slice Thin-Section Computed Tomography and Autofluorescence Bronchoscopy
Where Is the Heart after Left-Sided Pneumonectomy?
PET Scan in Lung Cancer: Current Recommendations and Innovation
PET/CT Fusion Scan in Lung Cancer: Current Recommendations and Innovations
Integration of Biomarkers and Imaging
Role of PET-CT in the Optimization of Thoracic Radiotherapy
Innovations in the Radiotherapy of Non–Small Cell Lung Cancer
Vaccines for Lung Cancer
Lung Cancer Late-Detection, Multimodality Strategy